<li>abobotulinumtoxina<p>oxcarbazepine decreases effects of abobotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>acetaminophen<p>oxcarbazepine decreases levels of acetaminophen by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>acetaminophen iv<p>oxcarbazepine decreases levels of acetaminophen iv by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>acetaminophen rectal<p>oxcarbazepine decreases levels of acetaminophen rectal by increasing metabolism. Minor/Significance Unknown. Enhanced metabolism incr levels of hepatotoxic metabolites.</p></li><li>alfentanil<p>oxcarbazepine will decrease the level or effect of alfentanil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>alfuzosin<p>oxcarbazepine will decrease the level or effect of alfuzosin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>alosetron<p>oxcarbazepine will decrease the level or effect of alosetron by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>amitriptyline<p>oxcarbazepine will increase the level or effect of amitriptyline by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.<span><br><br></span>oxcarbazepine will decrease the level or effect of amitriptyline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>amlodipine<p>oxcarbazepine will decrease the level or effect of amlodipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>armodafinil<p>oxcarbazepine will decrease the level or effect of armodafinil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>atazanavir<p>oxcarbazepine will decrease the level or effect of atazanavir by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>atracurium<p>oxcarbazepine decreases effects of atracurium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>biotin<p>oxcarbazepine decreases levels of biotin by unspecified interaction mechanism. Minor/Significance Unknown. Biotin supplementation may be necessary.</p></li><li>bosentan<p>oxcarbazepine will decrease the level or effect of bosentan by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>carbamazepine<p>carbamazepine decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>cevimeline<p>oxcarbazepine will decrease the level or effect of cevimeline by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>cimetidine<p>oxcarbazepine will increase the level or effect of cimetidine by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>cisatracurium<p>oxcarbazepine decreases effects of cisatracurium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>clarithromycin<p>oxcarbazepine will decrease the level or effect of clarithromycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>clomethiazole<p>oxcarbazepine will decrease the level or effect of clomethiazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>clomipramine<p>oxcarbazepine will decrease the level or effect of clomipramine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>cyanocobalamin<p>oxcarbazepine decreases levels of cyanocobalamin by inhibition of GI absorption. Applies only to oral form of both agents. Minor/Significance Unknown.</p></li><li>dapsone<p>oxcarbazepine will decrease the level or effect of dapsone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>delavirdine<p>oxcarbazepine will decrease the level or effect of delavirdine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>desipramine<p>oxcarbazepine will decrease the level or effect of desipramine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>dexmethylphenidate<p>dexmethylphenidate increases effects of oxcarbazepine by decreasing metabolism. Minor/Significance Unknown.</p></li><li>diazepam<p>oxcarbazepine will increase the level or effect of diazepam by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>disopyramide<p>oxcarbazepine will decrease the level or effect of disopyramide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>docetaxel<p>oxcarbazepine will decrease the level or effect of docetaxel by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>donepezil<p>oxcarbazepine will decrease the level or effect of donepezil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>doxycycline<p>oxcarbazepine decreases levels of doxycycline by increasing metabolism. Minor/Significance Unknown.</p></li><li>dutasteride<p>oxcarbazepine will decrease the level or effect of dutasteride by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>eplerenone<p>oxcarbazepine will decrease the level or effect of eplerenone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ethotoin<p>ethotoin decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>etoricoxib<p>oxcarbazepine will decrease the level or effect of etoricoxib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>eucalyptus<p>oxcarbazepine will decrease the level or effect of eucalyptus by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>finasteride<p>oxcarbazepine will decrease the level or effect of finasteride by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>fosphenytoin<p>fosphenytoin decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>galantamine<p>oxcarbazepine will decrease the level or effect of galantamine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>imatinib<p>oxcarbazepine will decrease the level or effect of imatinib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>imipramine<p>oxcarbazepine will decrease the level or effect of imipramine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>incobotulinumtoxina<p>oxcarbazepine decreases effects of incobotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>isradipine<p>oxcarbazepine will decrease the level or effect of isradipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>itraconazole<p>oxcarbazepine will decrease the level or effect of itraconazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ketoconazole<p>oxcarbazepine will decrease the level or effect of ketoconazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>lansoprazole<p>oxcarbazepine will increase the level or effect of lansoprazole by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>levocarnitine<p>oxcarbazepine decreases levels of levocarnitine by unspecified interaction mechanism. Minor/Significance Unknown.</p></li><li>levothyroxine<p>oxcarbazepine decreases levels of levothyroxine by increasing metabolism. Minor/Significance Unknown.</p></li><li>liothyronine<p>oxcarbazepine decreases levels of liothyronine by increasing metabolism. Minor/Significance Unknown.</p></li><li>methylphenidate<p>methylphenidate increases effects of oxcarbazepine by decreasing metabolism. Minor/Significance Unknown.</p></li><li>mibefradil<p>oxcarbazepine will decrease the level or effect of mibefradil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>montelukast<p>oxcarbazepine will decrease the level or effect of montelukast by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nimodipine<p>oxcarbazepine will decrease the level or effect of nimodipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>nitrendipine<p>oxcarbazepine will decrease the level or effect of nitrendipine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>onabotulinumtoxina<p>oxcarbazepine decreases effects of onabotulinumtoxina by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>oxybutynin<p>oxcarbazepine will decrease the level or effect of oxybutynin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>paclitaxel<p>oxcarbazepine will decrease the level or effect of paclitaxel by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>paclitaxel protein bound<p>oxcarbazepine will decrease the level or effect of paclitaxel protein bound by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>pancuronium<p>oxcarbazepine decreases effects of pancuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>pantoprazole<p>oxcarbazepine will decrease the level or effect of pantoprazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Unclear on net effect of pantoprazole action due to opposing effects by CYP450 enzymes; monitor<span><br><br></span>oxcarbazepine will increase the level or effect of pantoprazole by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown. Unclear on net effect of pantoprazole action due to opposing effects by CYP450 enzymes; monitor</p></li><li>parecoxib<p>oxcarbazepine will decrease the level or effect of parecoxib by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>perampanel<p>perampanel increases levels of oxcarbazepine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>phenobarbital<p>phenobarbital decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>phenytoin<p>phenytoin decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>pimozide<p>oxcarbazepine will decrease the level or effect of pimozide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>pioglitazone<p>oxcarbazepine will decrease the level or effect of pioglitazone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>propafenone<p>oxcarbazepine will decrease the level or effect of propafenone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>quinine<p>oxcarbazepine will decrease the level or effect of quinine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>rabeprazole<p>oxcarbazepine will decrease the level or effect of rabeprazole by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ramelteon<p>oxcarbazepine will decrease the level or effect of ramelteon by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>rapacuronium<p>oxcarbazepine decreases effects of rapacuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>rimabotulinumtoxinb<p>oxcarbazepine decreases effects of rimabotulinumtoxinb by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>rocuronium<p>oxcarbazepine decreases effects of rocuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>sage<p>sage decreases effects of oxcarbazepine by pharmacodynamic antagonism. Minor/Significance Unknown. Theoretical interaction; some species of sage may cause convulsions.</p></li><li>saxagliptin<p>oxcarbazepine will decrease the level or effect of saxagliptin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>succinylcholine<p>oxcarbazepine decreases effects of succinylcholine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>sufentanil<p>oxcarbazepine will decrease the level or effect of sufentanil by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>telithromycin<p>oxcarbazepine will decrease the level or effect of telithromycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>thyroid desiccated<p>oxcarbazepine decreases levels of thyroid desiccated by increasing metabolism. Minor/Significance Unknown.</p></li><li>troleandomycin<p>oxcarbazepine will decrease the level or effect of troleandomycin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>tubocurarine<p>oxcarbazepine decreases effects of tubocurarine by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>vecuronium<p>oxcarbazepine decreases effects of vecuronium by pharmacodynamic antagonism. Minor/Significance Unknown.</p></li><li>verapamil<p>verapamil decreases levels of oxcarbazepine by increasing metabolism. Minor/Significance Unknown.</p></li><li>vesnarinone<p>oxcarbazepine will decrease the level or effect of vesnarinone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vinblastine<p>oxcarbazepine will decrease the level or effect of vinblastine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vincristine<p>oxcarbazepine will decrease the level or effect of vincristine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vincristine liposomal<p>oxcarbazepine will decrease the level or effect of vincristine liposomal by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>vinorelbine<p>oxcarbazepine will decrease the level or effect of vinorelbine by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>voriconazole<p>oxcarbazepine will increase the level or effect of voriconazole by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>warfarin<p>oxcarbazepine will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C19 metabolism. Minor/Significance Unknown.</p></li><li>zaleplon<p>oxcarbazepine will decrease the level or effect of zaleplon by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>ziprasidone<p>oxcarbazepine will decrease the level or effect of ziprasidone by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zolpidem<p>oxcarbazepine will decrease the level or effect of zolpidem by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li><li>zonisamide<p>oxcarbazepine will decrease the level or effect of zonisamide by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.</p></li>